뉴로크린바이오사이언스 NBIX(NEUROCRINE BIOSCIENCES INC)

뉴로크린바이오사이언스

NBIX

NASDAQ

125.65
+ 0.65 (+0.52%)
24.11/22, USD

54명의 관심

최근 실적발표 24. 10/30

연환산 연간 분기

손익계산서 * 단위 : 백만달러(USD)

	24.09/30	24.06/30	24.03/31	23.12/31	23.09/30	23.06/30	23.03/31	22.12/31	22.09/30	22.06/30	22.03/31	21.12/31	21.09/30	21.06/30	21.03/31	20.12/31	20.09/30	20.06/30	20.03/31	19.12/31	19.09/30	19.06/30	19.03/31	18.12/31	18.09/30	18.06/30	18.03/31	17.12/31	17.09/30	17.06/30	17.03/31	16.12/31	16.09/30	16.06/30	16.03/31	15.12/31	15.09/30	15.06/30	15.03/31	14.12/31	14.09/30
매출액	2,243	2,120	1,982	1,887	1,784	1,673	1,599	1,489	1,389	1,297	1,208	1,134	1,069	1,032	1,045	1,046	1,042	1,006	887	788	675	605	519	451	414	323	233	162	67	6	0	15	15	15	15	20	20	20	20	0	0.73
매출원가	33	36	39	40	39	34	27	23	20	18	16	14	13	12	11	10	10	9	8	7	6	6	5	5	4	3	2	1.25	0.49	0.06	0	0	0	0	0	0	0	0	0	0	0
매출총이익	2,210	2,083	1,943	1,847	1,745	1,639	1,571	1,466	1,369	1,279	1,192	1,119	1,056	1,020	1,035	1,036	1,032	997	878	781	669	599	513	446	410	320	231	160	67	6	0	15	15	15	15	20	20	20	20	0	0.73
판매관리비	938	908	888	888	852	834	795	753	726	695	655	583	533	491	445	433	428	400	384	354	322	298	278	249	236	220	200	170	137	111	84	68	53	47	39	32	29	22	19	18	16
연구개발비	683	630	585	565	546	511	501	464	433	418	357	328	307	284	290	275	264	240	221	200	179	169	145	156	117	104	89	92	119	117	122	94	94	97	89	81	75	63	54	46	40
영업이익	579	536	464	251	204	151	132	249	109	66	74	103	211	122	136	163	140	274	232	72	45	9	-27	37	27	-33	-89	-131	-189	-222	-206	-147	-132	-129	-113	-94	-84	-65	-54	-64	-55
EBITDA	550	474	495	358	274	256	112	237	109	46	129	138	194	108	135	148	145	260	228	86	65	56	-3	56	44	-19	-76	-121	-180	-213	-198	-140	-124	-122	-106	-88	-78	-60	-49	-60	-51
영업외이익	-55	-87	8	86	50	87	-37	-28	-15	-33	44	25	-27	-24	-10	-24	-3	-23	-12	6	13	41	19	16	13	11	10	8	7	7	6	6	6	6	6	5	5	4	4	4	4
법인세	136	108	100	82	61	58	25	59	24	3	24	12	-288	-295	-307	-301	10	14	12	10	6	1.00	0.20	0.70	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
중단손익	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
순이익	386	339	370	250	191	176	64	155	58	12	71	90	445	365	402	407	93	205	177	37	21	18	-39	21	10	-52	-106	-143	-194	-220	-200	-141	-126	-123	-107	-89	-79	-60	-50	-61	-52

재무상태표 * 단위 : 백만달러(USD)

	24.09/30	24.06/30	24.03/31	23.12/31	23.09/30	23.06/30	23.03/31	22.12/31	22.09/30	22.06/30	22.03/31	21.12/31	21.09/30	21.06/30	21.03/31	20.12/31	20.09/30	20.06/30	20.03/31	19.12/31	19.09/30	19.06/30	19.03/31	18.12/31	18.09/30	18.06/30	18.03/31	17.12/31	17.09/30	17.06/30	17.03/31	16.12/31	16.09/30	16.06/30	16.03/31	15.12/31	15.09/30	15.06/30	15.03/31	14.12/31	14.09/30
현금성자산	349	140	396	251	294	160	104	263	212	163	270	341	311	368	356	187	429	418	190	116	171	146	78	147	201	172	180	259	272	314	69	88	105	91	120	79	71	137	175	36	33
단기투자	879	899	814	781	801	817	791	726	587	485	395	371	455	517	521	614	519	533	585	558	504	479	451	509	440	342	285	261	243	216	171	224	253	301	266	305	310	253	200	163	151
매출채권등	481	468	451	439	418	388	392	350	301	279	264	186	164	159	148	157	157	148	149	127	115	95	72	57	54	43	45	31	30	6	0	0	0	0	15	0	0	0	30	0	0
재고자산	46	43	37	38	29	32	33	35	37	29	29	31	26	28	30	28	21	22	21	17	11	12	13	11	6	0	0	1.02	0.24	0.13	0	0	0	0	0	0	0	0	0	0	0
장기투자	771	781	864	849	588	516	380	402	458	489	632	624	549	377	289	265	225	246	275	356	254	224	233	216	185	249	276	247	210	206	38	43	30	27	49	82	102	114	115	37	67
유형자산	337	343	346	347	150	149	147	146	151	159	159	156	149	150	142	127	114	117	115	116	102	89	86	34	29	19	12	11	9	7	7	6	6	6	4	3	3	3	3	3	2
무형자산	35	34	34	36	35	37	37	37	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
이연세자산	454	420	378	363	383	379	337	306	319	328	325	315	310	316	326	319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
기타자산	183	178	151	147	151	137	138	104	78	73	71	50	54	42	35	37	38	31	27	17	23	21	24	19	19	16	9	7	7	6	4	3	5	5	4	5	6	5	5	4	4
자산총계	3,535	3,305	3,472	3,251	2,848	2,613	2,360	2,369	2,143	2,006	2,145	2,073	2,017	1,956	1,846	1,735	1,503	1,516	1,362	1,306	1,180	1,067	958	993	934	841	806	818	772	754	289	365	399	430	459	475	492	511	528	243	258
매입채무등	393	359	417	449	503	392	356	348	298	266	236	226	206	191	172	169	171	137	126	141	102	95	68	86	72	61	46	54	37	27	0.85	26	2	2	2	3	1.20	1.04	1.27	0.25	0.90
단기차입금	0	0	259	170	170	170	0	169	169	0	0	0	0	0	0	0	425	420	0	409	0	0	0	0	384	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
장기차입금	251	256	253	258	86	89	260	94	97	269	480	440	437	435	430	412	83	84	500	87	478	465	461	388	0	379	374	370	365	361	0	0	0	0	0	0	0	0	0	0	0
이연수익	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	0	0
이연세부채	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
기타부채	172	181	157	142	87	110	60	50	35	48	37	32	28	51	39	28	20	44	36	32	25	23	20	38	20	14	12	12	12	11	31	14	36	37	34	38	34	33	32	34	33
부채총계	816	796	1,086	1,019	846	760	675	661	599	582	753	699	671	677	641	609	698	684	662	669	605	583	548	512	486	464	442	445	425	409	42	50	48	49	46	50	45	44	43	34	34
이익잉여금	81	-49	-114	-157	-305	-388	-483	-407	-496	-564	-547	-636	-629	-651	-693	-725	-1,073	-1,016	-1,095	-1,133	-1,167	-1,220	-1,272	-1,178	-1,196	-1,247	-1,241	-1,199	-1,206	-1,195	-1,135	-1,056	-1,012	-975	-934	-915	-886	-851	-827	-826	-807
기타포괄익	15	3	3	7	-2	-1	-3	-8	-14	-12	-9	-2	0	1	1	2	3	5	-1	1	2	1	0	-2	-2	-3	-4	-2	-1	-1	0	0	0	0	0	-1	-1	0	0	0	0
자본총계	2,719	2,509	2,386	2,232	2,002	1,853	1,685	1,708	1,545	1,423	1,391	1,374	1,346	1,279	1,206	1,126	804	831	700	637	575	484	409	481	448	377	364	372	348	345	247	315	352	381	413	424	447	467	485	209	224
주식수(만주)	10,430	10,390	10,360	10,100	10,110	10,020	9,710	9,890	9,900	9,560	9,760	9,790	9,770	9,770	9,820	9,780	9,330	9,820	9,700	9,570	9,610	9,480	9,110	9,540	9,679	9,010	8,952	8,808	8,832	8,806	8,728	8,671	8,678	8,669	8,649	8,449	8,585	8,551	8,034	7,457	7,594

현금흐름표 * 단위 : 백만달러(USD)

	24.09/30	24.06/30	24.03/31	23.12/31	23.09/30	23.06/30	23.03/31	22.12/31	22.09/30	22.06/30	22.03/31	21.12/31	21.09/30	21.06/30	21.03/31	20.12/31	20.09/30	20.06/30	20.03/31	19.12/31	19.09/30	19.06/30	19.03/31	18.12/31	18.09/30	18.06/30	18.03/31	17.12/31	17.09/30	17.06/30	17.03/31	16.12/31	16.09/30	16.06/30	16.03/31	15.12/31	15.09/30	15.06/30	15.03/31	14.12/31	14.09/30
영업활동	476	530	645	390	409	296	255	339	201	164	129	257	347	265	280	229	232	350	295	147	100	71	27	101	91	13	-55	-94	-167	-188	-154	-106	-90	-77	-49	-38	-38	-32	-56	-47	-43
투자활동	-260	-382	-480	-467	-381	-345	-188	-177	-38	-103	-225	-130	-302	-150	34	4	-14	-125	-219	-211	-151	-111	-145	-243	-196	-186	-365	-251	-177	-98	100	113	120	29	-9	-196	-202	-151	-156	-105	-100
재무활동	-161	-169	127	65	55	47	-232	-234	-257	-261	18	27	-159	-162	-149	-158	40	47	36	32	22	14	16	30	33	31	531	517	511	509	4	2	3	3	4	277	278	278	276	139	137
환율변동	0.60	0.30	0.30	0.30	-1.30	-1.30	-1.30	-1.30	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
현금의증감	55	-21	293	-12	82	-3	-166	-73	-94	-200	-78	154	-114	-47	166	75	257	272	112	-32	-29	-25	-101	-112	-71	-142	111	171	168	223	-51	9	33	-46	-55	43	37	95	65	-14	-6
자본적지출	-36	-36	-31	-28	-25	-15	-17	-17	-24	-31	-27	-23	-19	-14	-14	-11	-9	-12	-12	-15	-18	-27	-27	-25	-21	-12	-7	-7	-5	-3	-5	-4	-5	-4	-2	-2	-2	-1.49	-2	-2	-1.32
잉여현금	440	495	614	362	385	281	237	323	177	133	102	233	328	251	266	218	222	337	283	132	82	44	0.47	77	70	2	-63	-101	-171	-191	-159	-110	-94	-81	-51	-40	-40	-33	-57	-49	-44

본 서비스는 투자판단에 참고용으로만 사용하실 수 있으며, 모든 투자판단은 투자자 본인의 책임으로 당사는 그 결과에 대해 법적인 일체의 책임을 지지 않습니다.

data from Quandl and Sharadar

미주미초이스 신청하기

종목검색

뉴로크린바이오사이언스

손익계산서 * 단위 : 백만달러(USD)

재무상태표 * 단위 : 백만달러(USD)

현금흐름표 * 단위 : 백만달러(USD)